David Hymel - Search Results

Year	Number of Results
2008	2
2009	4
2012	1
2014	1
2015	1
2016	1
2017	7
2018	1
2019	3
2020	5
2021	1
2022	2
2024	0

1

Chemically Programmable and Switchable CAR-T Therapy.

Qi J, Tsuji K, Hymel D, Burke TR Jr, Hudecek M, Rader C, Peng H. Qi J, et al. Among authors: hymel d. Angew Chem Int Ed Engl. 2020 Jul 13;59(29):12178-12185. doi: 10.1002/anie.202005432. Epub 2020 May 18. Angew Chem Int Ed Engl. 2020. PMID: 32329959 Free PMC article.

2

Stable and Potent Selenomab-Drug Conjugates.

Li X, Nelson CG, Nair RR, Hazlehurst L, Moroni T, Martinez-Acedo P, Nanna AR, Hymel D, Burke TR Jr, Rader C. Li X, et al. Among authors: hymel d. Cell Chem Biol. 2017 Apr 20;24(4):433-442.e6. doi: 10.1016/j.chembiol.2017.02.012. Epub 2017 Mar 16. Cell Chem Biol. 2017. PMID: 28330604 Free PMC article.

3

Further Exploration of Hydrazine-Mediated Bioconjugation Chemistries.

Mailig M, Hymel D, Liu F. Mailig M, et al. Among authors: hymel d. Org Lett. 2020 Aug 21;22(16):6677-6681. doi: 10.1021/acs.orglett.0c02545. Epub 2020 Aug 13. Org Lett. 2020. PMID: 32786214

4

Current progress and future perspectives in the development of anti-polo-like kinase 1 therapeutic agents.

Park JE, Hymel D, Burke TR Jr, Lee KS. Park JE, et al. Among authors: hymel d. F1000Res. 2017 Jun 29;6:1024. doi: 10.12688/f1000research.11398.1. eCollection 2017. F1000Res. 2017. PMID: 28721210 Free PMC article. Review.

5

Synthetic cell surface receptors for delivery of therapeutics and probes.

Hymel D, Peterson BR. Hymel D, et al. Adv Drug Deliv Rev. 2012 Jun 15;64(9):797-810. doi: 10.1016/j.addr.2012.02.007. Epub 2012 Feb 25. Adv Drug Deliv Rev. 2012. PMID: 22401875 Free PMC article. Review.

6

Unanticipated Characteristics of a Selective, Potent Neuromedin-U Receptor 2 Agonist.

Mehrotra S, Lam S, Glenn E, Hymel D, Sanford CA, Liu Q, Herich J, Wulff BS, Meek TH. Mehrotra S, et al. Among authors: hymel d. ACS Bio Med Chem Au. 2022 May 27;2(4):370-375. doi: 10.1021/acsbiomedchemau.2c00016. eCollection 2022 Aug 17. ACS Bio Med Chem Au. 2022. PMID: 37102164 Free PMC article.

7

Development of ultra-high affinity bivalent ligands targeting the polo-like kinase 1.

Tsuji K, Hymel D, Ma B, Tamamura H, Nussinov R, Burke TR Jr. Tsuji K, et al. Among authors: hymel d. RSC Chem Biol. 2022 Jul 15;3(9):1111-1120. doi: 10.1039/d2cb00153e. eCollection 2022 Aug 31. RSC Chem Biol. 2022. PMID: 36128509 Free PMC article.

8

Enhancing polo-like kinase 1 selectivity of polo-box domain-binding peptides.

Zhao XZ, Hymel D, Burke TR Jr. Zhao XZ, et al. Among authors: hymel d. Bioorg Med Chem. 2017 Oct 1;25(19):5041-5049. doi: 10.1016/j.bmc.2017.02.063. Epub 2017 Feb 28. Bioorg Med Chem. 2017. PMID: 28285924 Free PMC article.

9

Colorado community pharmacists' survey and their perspectives regarding marijuana.

Shea LA, Goldwire MA, Hymel D, Bui D. Shea LA, et al. Among authors: hymel d. SAGE Open Med. 2020 Jul 29;8:2050312120938215. doi: 10.1177/2050312120938215. eCollection 2020. SAGE Open Med. 2020. PMID: 32821385 Free PMC article.

10

Adipose tissue collagen VI in obesity.

Pasarica M, Gowronska-Kozak B, Burk D, Remedios I, Hymel D, Gimble J, Ravussin E, Bray GA, Smith SR. Pasarica M, et al. Among authors: hymel d. J Clin Endocrinol Metab. 2009 Dec;94(12):5155-62. doi: 10.1210/jc.2009-0947. Epub 2009 Oct 16. J Clin Endocrinol Metab. 2009. PMID: 19837927 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

27 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year